Pure Global

Sexual Health Advocacy for Guys - a Text Messaging-based HIV Prevention Program for Guys Who Are Into Guys - Trial NCT06230367

Access comprehensive clinical trial information for NCT06230367 through Pure Global AI's free database. This phase not specified trial is sponsored by Center for Innovative Public Health Research and is currently Recruiting. The study focuses on HIV Infections. Target enrollment is 5000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06230367
Recruiting
behavioral
Trial Details
ClinicalTrials.gov • NCT06230367
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Sexual Health Advocacy for Guys - a Text Messaging-based HIV Prevention Program for Guys Who Are Into Guys
Harnessing the Power of Text Messaging to Reduce HIV Incidence in Adolescent Males Across the United States

Study Focus

HIV Infections

Sexual health advocacy for guys

Interventional

behavioral

Sponsor & Location

Center for Innovative Public Health Research

San Clemente,San Clemente, United States of America

Timeline & Enrollment

N/A

Jan 15, 2024

Jul 31, 2026

5000 participants

Primary Outcome

HIV Incidence

Summary

SHAG is a text messaging-based HIV prevention program designed for cisgender sexual minority
 boys and men 13-20 years of age across the United States. Investigators will test it against
 a control group that receives messages about healthy lifestyle.

ICD-10 Classifications

HIV disease resulting in other viral infections
HIV disease resulting in other bacterial infections
HIV disease resulting in multiple infections
Acute HIV infection syndrome
HIV disease resulting in other infectious and parasitic diseases

Data Source

ClinicalTrials.gov

NCT06230367

Non-Device Trial